Mucosal vaccination against serogroup B meningococci: induction of bactericidal antibodies and cellular immunity following intranasal immunization with NadA of Neisseria meningitidis and mutants of Escherichia coli heat-labile enterotoxin.
about
Role of ARF6, Rab11 and external Hsp90 in the trafficking and recycling of recombinant-soluble Neisseria meningitidis adhesin A (rNadA) in human epithelial cellsCharacterization of MspA, an immunogenic autotransporter protein that mediates adhesion to epithelial and endothelial cells in Neisseria meningitidis.Virulence determinants involved in differential host niche adaptation of Neisseria meningitidis and Neisseria gonorrhoeae.Characterization of an autotransporter adhesin protein shared by Burkholderia mallei and Burkholderia pseudomallei.Microsatellite instability regulates transcription factor binding and gene expressionInduction of protective serum meningococcal bactericidal and diphtheria-neutralizing antibodies and mucosal immunoglobulin A in volunteers by nasal insufflations of the Neisseria meningitidis serogroup C polysaccharide-CRM197 conjugate vaccine mixedStructure of the meningococcal vaccine antigen NadA and epitope mapping of a bactericidal antibodyIS1301 fingerprint analysis of Neisseria meningitidis strains belonging to the ET-15 clone.Phage display revisited: Epitope mapping of a monoclonal antibody directed against Neisseria meningitidis adhesin A using the PROFILER technology.B cells and antibodies in the defense against Mycobacterium tuberculosis infectionTowards an improved serogroup B Neisseria meningitidis vaccine.Transcutaneous immunization with cross-reacting material CRM(197) of diphtheria toxin boosts functional antibody levels in mice primed parenterally with adsorbed diphtheria toxoid vaccine.Intranasal vaccines for protection against respiratory and systemic bacterial infections.Mucosal vaccination against bacterial respiratory infections.Challenges and progress in the development of a serogroup B meningococcal vaccine.Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines.Specificity of subcapsular antibody responses in Ethiopian patients following disease caused by serogroup A meningococci.SadA, a trimeric autotransporter from Salmonella enterica serovar Typhimurium, can promote biofilm formation and provides limited protection against infection.Human heat shock protein (Hsp) 90 interferes with Neisseria meningitidis adhesin A (NadA)-mediated adhesion and invasion.
P2860
Q27335545-7F80E4EA-72F1-4CEB-9AAC-942FA7F26586Q30159832-BFC8E6CD-B85E-4156-BADA-30DF209A2DDEQ33348906-812AA690-B346-4AC6-BBF6-A9E2DAEA1381Q33611911-D69CCC8E-9860-4B4D-BEA7-3CC66BECC06CQ33928490-D711E5E8-862C-48A7-B645-441A01A5DB43Q34194667-D7D02E81-0E1A-48F5-89F5-25E67EC2BF5FQ34661129-5FCAED74-1DDA-4957-AD48-5E67D85500E7Q35690291-9E044D71-E438-4488-BA3C-AD942A900541Q35952404-A8BF37DA-C4D5-447C-BE2A-32A4A031D97EQ36238031-002ED55D-A849-410C-89A9-C9629BE4DBA5Q36327065-E16E62BC-2895-4EA3-92B7-AFF61A8BE934Q36539669-D7C88CE5-75C3-4BC0-80D6-8309BB58E5E6Q36837156-43CEE06B-C3DA-4824-8BB2-DC5D3C7A8AC8Q37290114-36C7B676-E9DB-47CF-B172-AB0E247C4209Q37503243-D754DE38-9B8B-4FC8-A62C-870511E77B25Q37857249-9F1CB369-B04E-40C2-8389-9CB9FEDAD441Q38606992-2CC2D96F-598A-47DA-9459-D9EFD2CF54C6Q40387294-EAA066F4-E5E0-49D2-9559-ECA69B4CA849Q44358302-37B915E9-1DB4-481F-8F8B-44708E03B211
P2860
Mucosal vaccination against serogroup B meningococci: induction of bactericidal antibodies and cellular immunity following intranasal immunization with NadA of Neisseria meningitidis and mutants of Escherichia coli heat-labile enterotoxin.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Mucosal vaccination against se ...... coli heat-labile enterotoxin.
@ast
Mucosal vaccination against se ...... coli heat-labile enterotoxin.
@en
Mucosal vaccination against se ...... coli heat-labile enterotoxin.
@nl
type
label
Mucosal vaccination against se ...... coli heat-labile enterotoxin.
@ast
Mucosal vaccination against se ...... coli heat-labile enterotoxin.
@en
Mucosal vaccination against se ...... coli heat-labile enterotoxin.
@nl
prefLabel
Mucosal vaccination against se ...... coli heat-labile enterotoxin.
@ast
Mucosal vaccination against se ...... coli heat-labile enterotoxin.
@en
Mucosal vaccination against se ...... coli heat-labile enterotoxin.
@nl
P2093
P2860
P921
P1476
Mucosal vaccination against se ...... coli heat-labile enterotoxin.
@en
P2093
Alan Huett
Beatrice Arico
Christine Hale
Edel A McNeela
Frances Bowe
Gordon Dougan
Kingston H G Mills
Marzia M Giuliani
Simon Clare
P2860
P304
P356
10.1128/IAI.72.7.4052-4060.2004
P407
P577
2004-07-01T00:00:00Z